High response rates after neoadjuvant cytoreductive...

European Journal of Surgical Oncology (EJSO) 2019 / 02 Vol. 45; Iss. 2

High response rates after neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma, REDUCTOR trial

Blankenstein, S., Rohaan, M., Klop, M., Van der Hiel, B., Van de Wiel, B., Peeper, D., Haanen, J., van Akkooi, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
45
Journal:
European Journal of Surgical Oncology
DOI:
10.1016/j.ejso.2018.10.118
Date:
February, 2019
File:
PDF, 53 KB
2019
Conversion to is in progress
Conversion to is failed